Denver, Colorado, USA
Mermaid Medical's Angel® Catheter Wins Premier Breakthrough Innovation Award 2023
We are proud to announce that the Angel® Catheter has been honored with the Premier Breakthrough Innovation Award for the year 2023. This tribute not only recognizes the exceptional efforts of our dedicated team but also confirms our commitment to transforming healthcare and saving lives.
The Angel® Catheter is a cutting-edge IVC filter combined with a triple lumen central venous catheter, a fusion of innovation and functionality designed to provide unparalleled protection and care for critically ill patients. Unlike any other IVC filter on the market, the Angel® Catheter promises not only prophylactic Pulmonary Embolism (PE) protection but also guarantees IVC filter retrieval—an extraordinary promise that sets it apart as a game-changing solution.
One of the most significant challenges faced by healthcare professionals when treating critically ill patients is the risk of PE. The Angel® Catheter addresses this concern by offering immediate and effective PE protection during a critical and frequently untreated window, for patients who are critically ill.
The Premier Breakthrough Innovation Award celebrates forward-thinking companies that are making a difference in healthcare, and we are humbled to be among the recipients. This recognition inspires us to continue pushing the boundaries of medical technology and finding innovative solutions that will benefit communities worldwide.
At Mermaid Medical, we firmly believe that the future of healthcare lies in continuous innovation and collaboration. As we celebrate this milestone achievement, we remain committed to our mission of providing life-saving medical devices that positively impact the lives of patients and healthcare professionals alike. With this recognition, we are more determined than ever to continue our pursuit of excellence and shape a healthier world through groundbreaking medical technology.
Mermaid Medical Group announces new exclusive distribution deal on the COBRA-OS® device for REBOA procedures from Front Line Medical Technologies Inc.
Mermaid Medical is proud to announce the appointment of Marcus Kildegaard Nielsen as the new global Sales Director, effective September 1st, 2024. Over the past six years, Marcus has made significant contributions in sales and marketing, bringing the right skills, ambitions, and mindset to ensure we keep driving the business forward.
Mermaid Medical proudly welcomes Daniel Nilsson Lennartz as the new Business Development Director, effective September 1st, 2024. As one of the co-founders, Daniel brings invaluable insights and expertise that will continue to drive the company’s growth and long-term success.